Overview

Although there is some debate about the extent of counterfeits in the world's pharmaceutical supply chain, it is undeniable that counterfeit and substandard medicines are a growing and dangerous business. They can cause major moral, reputational and financial damage to pharmaceutical manufacturers, as well as untold harm to patients who are deceived by the fake version of their medication. This book provides a concise account of the history, policy and law, and financial and economic aspects surrounding pharmaceutical product counterfeiting, as well as some of the countermeasures available to organisations. This valuable publication discusses the problems experienced in lesser developed countries, and reports the activities and findings of governments and agencies around the world. The growth in e-commerce means that the Internet has become the primary tool in the advertisement and sale of counterfeit pharmaceuticals by criminal organisations. The safety concerns regarding illicit online pharmacies are reviewed and an overview is given of the regulatory efforts attempting to stem their negative effects. The book provides important information on creating an overall anti-counterfeit strategy and a review of current countermeasures, including authentication and tracing programmes. In addition, the book compares some of the problems that have been experienced with those encountered by other product areas in relation to counterfeiting. Important lessons have been learned by other industries, including fine art, wine, diamonds, currency and aeroplane parts. With the inclusion of economic and financial models and projections as well as real-life case studies, this book is essential reading for individuals and organisations affected by this complex issue.

Full Product Details

9781906799083

Table of Contents

Reviews

Author Information

Professor Albert I. Wertheimer received his BS degree in Pharmacy from the University of Buffalo, New York. He earned a Master of Business Administration (MBA) from the State University of New York at Buffalo and his PhD from Purdue University in Lafayette, Indiana. He conducted post-doctoral research at the Department of Social Medicine of St Thomas' Hospital Medical School in London. He is currently Professor of Pharmacy Economics in the Pharmacy Practice Department of Temple University School of Pharmacy in Philadelphia, Pennsylvania. He is the author or co-author of over 400 articles in scientific and professional journals, and an author or editor of 32 books. He has lectured and consulted in more than 60 countries. Dr. Perry G. Wang received his BS degree in Chemistry from Shandong University, China. He earned his MS and PhD degrees in Environmental Engineering from Oregon State University, USA. He is currently a research chemist in the Office of Regulatory Science, Center for Food Safety and Applied Nutrition, US Food and Drug Administration (US FDA) in College Park, Maryland. His current research focuses on developing analytical methods for constituents in cosmetics and dietary supplements by GC/MS/MS and LC/MS/MS. He has edited or co-edited three books and published numerous peer-reviewed papers in drug analysis, cosmetics and food safety.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available